Seres Therapeutics, Inc. Notes Payable, Current
Seres Therapeutics, Inc. (MCRB) had Notes Payable, Current of $0 as of 2023-12-31, per its 8-K filed 2024-08-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2024-08-15
- 2023-12-31: Notes Payable, Current $0.00.
- 2023-09-30: Notes Payable, Current $0.00.
- 2023-06-30: Notes Payable, Current $0.00.
- 2023-03-31: Notes Payable, Current $0.00.
| Period end | Notes Payable, Current |
|---|---|
| 2023-12-31 | $0.00 8-K · filed 2024-08-15 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $456.00K 8-K · filed 2024-08-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-07 |
| 2021-09-30 | $9.35M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $6.30M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $3.34M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $454.00K 10-K · filed 2022-03-01 |
| 2015-06-30 | $1.20M 10-Q · filed 2015-08-10 |
| 2014-12-31 | $1.20M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |